Artificial intelligence (AI) is of great interest to researchers and practitioners as a means of achieving the necessary progress in the pharmaceutical industry.
Thanks to AI and ML, pharmaceutical organizations have been able to quickly identify and diagnose new diseases, as these technologies are able to analyze huge volumes of data.
Large pharma companies use AI to transform production, sales, marketing, and analysis business processes.
AI will impact areas where human skills are suited to the maximum of their capabilities.
The reality, experts say, is that AI has been around for decades, but several trends over the last few years are now providing biopharmaceutical R&D with real opportunities.